Vaginal surgery in CL
Vaginal surgery in CL section, includes general infrmation about Vaginal surgery Procedure, Vaginal surgery CL Local News, Vaginal surgery CL Surgeon Locator and other Vaginal surgery related material.
Vaginal surgery Procedure
A woman’s look, or feel, in her vaginal and pubic region has a significant importance in a woman’s life. It is closely related to her self-esteem, and to the actual and expected excitement involved with her sexual life and desire.
Discomfort in a woman’s vaginal area can severely affects her psychological state.
Many women today seek cosmetic surgery solutions that will improve their look and feel in their pubic regions. Such solutions may include reconstruction (mostly tightening) of the vagina, cosmetic procedures in the labia (size-reduction and beautification), and others. Intimate Plastic Surgery corrects dysfunctions and improves the woman's hidden aesthetics
As well, there is a growing demand today, mostly due to ethnic and religious requirements, to re-construct woman’s hymen.
In general, cosmetic vaginal surgeries may be divided in the following groups:
• Vaginoplasty (mainly vaginal tightening and muscle re-building)
• Labiaplasty (reducing and/or reshaping the external genital structures)
• Hymenoplasty (re-construction of the hymen, to a “near-virginity” state).
Birth-giving, aging, and genetic factors often cause the vaginal muscles to loosen and weaken, sometimes even tear. The diameter of the vagina gets bigger and there is a loss of feeling.
There are three main technical approaches in vaginal surgeries:
• Scalpel
• Laser
• Radiosurgical techniques
The candidate will consult her physician and the surgeon about the methods the surgeon uses in vaginal procedures. Each technique has its advantages, and it all depends on the expert surgeon’s experience and the specific patient’s needs and preference.
Most patients are very happy after vaginal tightening surgery. Their regained vaginal muscle tone significantly improves their quality of life in general, and the quality of their intimate sex-life in particular.
Careful assessment of signs and symptoms, along with an in-depth clinical examination, will be made before any surgical decision. As well, any existing vaginal disease or infection will be diagnosed and treated before proceeding into cosmetic surgery.
According to the scientific medical paper of Masters and Johnson, sexual gratification is directly related to the amount of frictional forces generated. It is not, however, a solution for sexual dysfunction, lack of interest or arousal, or orgasmic inadequacy.
Labiaplasty can be combined with other cosmetic surgeries. Most women who wish to undergo labiaplasty also choose tummy tucks and liposuction procedures in parallel.
Other Vaginal surgery Procedures
All Body Procedures
Vaginal surgery CL (current)
Vaginal surgery CL Buttock Augmentation
Vaginal surgery CL Calf Augmentation
Vaginal surgery CL Liposuction
Vaginal surgery CL Body Contouring
More CL info...
Chile National Parks 1. Lauca
2. Volc?n Isluga
3. Llullaillaco
4. Pan de Az?car
5. Llanos de Challes
6. Nevado Tres Cruces
7. Bosque de Fray Jorge
8. La Campana
9. Archipi?lago Juan Fern?ndez
10. Rapa Nui
11. Palmas de Cocal?n
12. Laguna del Laja
13. Huerquehue
14. Villarrica
15. Nahuelbuta
16. Tolhuaca
17. Conguillio
18. Puyehue
19. Vicente P?rez Rosales
20. Alerce Andino
21. Chiloe
22. Hornopir?n
23. Corcovado
24. Isla Guamblin
25. Laguna San Rafael
26. Queulat
27. Isla Magdalena
28. Bernardo OHiggins
29. Torres del Paine National Park
30. Pali Aike
31. Alberto de Agostini
32. Cabo de Hornos
Chile Regions
North
Central
South
Extreme South note: Argentina and Chile's claims to Antarctica overlap. However, under the terms of the Antarctic Treaty, no country's territorial claims are exercised or recognized.
Plastic Surgery News...
- India is in the midst of a catastrophic epidemic of smoking deaths, which is expected to cause about one million (10 lakh) deaths a year during the 2010s - including one in five of all male deaths and one in 20 of all female deaths at ages 30-69. On average, male bidi smokers lose about six years of life, female bidi smokers lose about eight years and male cigarette smokers lose about ten years.
Objective To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV).
Design A randomized, double-blind, placebo-controlled study with a crossover arm for those who failed treatment.
Setting A US multicenter outpatient study.
Patients A total of 19 subjects enrolled among 5 centers, 9 randomized to receive dapsone and 10 to receive placebo. Inclusion criteria were biopsy and direct immunofluorescence-proven PV controlled with glucocorticoids and/or cytotoxic agents, disease in maintenance phase, and aged 18 to 80 years. Physicians had tried at least 2 tapers of glucocorticoids unsuccessfully and had 30 days of stable steroid dosage. Treatment for any patient unable to taper glucocorticoids by more than 25% within 4 months was declared a failure, and the patient was allowed to switch to the opposite medication while maintaining the double-blind.
Main Outcome Measure The ability of patients to taper to 7.5 mg/d or less within 1 year of reaching the maximum dosage of the study drug.
Results Of the 9 patients receiving dapsone, 5 were successfully treated, 3 failed treatment, and 1 dropped out of the study. Of the 10 patients receiving placebo, 3 were successfully treated, and 7 failed treatment. This primary end point favored the dapsone-treated group but was not statistically significant (P = .37). Four patients who failed treatment while receiving placebo were switched to treatment with dapsone. Of these, 3 were successfully treated after switching to dapsone treatment, and 1 failed treatment. We found that, overall, 8 of 11 patients (73%) receiving dapsone vs 3 of 10 (30%) receiving placebo reached the primary outcome of a prednisone dosage of 7.5 mg/d or less.
Conclusion This trial demonstrates a trend to efficacy of dapsone as a steroid-sparing drug in maintenance-phase PV.
Trial Registration clinicaltrials.gov Identifier: NCT00429533